There are 203 resources available
Q&A and discussion
Session: Artificial intelligence (AI) in drug development
Resources:
Webcast
Q&A and discussion
Session: New drugs for new targets
Resources:
Webcast
Early clinical trials: What are the most important questions that patients need to have addressed?
Presenter: Helen Bulbeck
Session: Workshop in collaboration with ESMO YOC: Patient participatory research
Resources:
Webcast
Improving patient participatory research in early clinical trials: Successes and where we can do better
Presenter: Lesley Seymour
Session: Workshop in collaboration with ESMO YOC: Patient participatory research
Resources:
Slides
Webcast
Q&A and discussion
Session: Workshop in collaboration with ESMO YOC: Patient participatory research
Resources:
Webcast
Evolving combinations: ‘Second generation’ IO checkpoints
Presenter: Emanuela Romano
Session: Novel combinations
Resources:
Slides
Webcast
Introduction
Presenter: Giovanni Abbadessa
Session: The corporate and investor mindset: What types of anti-cancer drugs and clinical research proposals will be prioritised in the near term?
Resources:
Slides
Webcast
Next frontiers of ADCs combinations
Presenter: Daniel Shao Weng Tan
Session: Novel combinations
Resources:
Slides
Webcast
The small company perspective
Presenter: Laura Soucek
Session: The corporate and investor mindset: What types of anti-cancer drugs and clinical research proposals will be prioritised in the near term?
Resources:
Slides
Webcast
Therapeutic potential of harnessing NK cells
Presenter: Eric Vivier
Session: Novel combinations
Resources:
Slides
Webcast